Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Ganfort approved for glaucoma in E.U.

May 29, 2006

Chemokine CXCR4 antagonists reported by Merck & Co.

May 25, 2006

QR-435 to be studied for ocular herpes in animals

May 25, 2006

Hsp90 inhibitor shows activity in a murine model of choroidal neovascularization

May 18, 2006

Primate lentiviral vector promotes stable gene transfer in the retina in preclinical studies

May 17, 2006

Novel formulation of pegaptanib demonstrates sustained release in vivo

May 17, 2006

Merck & Co. prepares and tests novel calcium-activated potassium channel blockers for glaucoma

May 17, 2006

Snapshots on genetically engineered therapeutic strategies for choroidal neovascularization

May 16, 2006

SurModics grants Bausch & Lomb genistein license in retinal diseases

May 15, 2006

Laureate Pharma and Iconic Therapeutics sign hI-con1 manufacturing agreement

May 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...